Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Jurnal Intelek Insan Cendikia Journal Health of Indonesian
Ilhawa Zahra
Unknown Affiliation
Religion Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Health Professions Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Optimizing COVID-19 Therapy: Analysis of Prescription Profiles in Non-Comorbid Inpatients to Enhance Treatment Strategies and Clinical Outcomes Fendy Prasetyawan; Yuneka Saristiana; Faisal Akhmal Muslikh; Ratna Mildawati; Ilhawa Zahra
Journal Health of Indonesian Vol. 1 No. 02 (2023): Journal Health of Indonesian, July 2023
Publisher : Paspama Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This study explores the clinical characteristics, treatment patterns, and outcomes of COVID-19 inpatients without comorbidities, aiming to contribute valuable insights to the management of the disease. Through meticulous data collection from medical records of 468 confirmed COVID-19 patients admitted to Gambiran Regional General Hospital between April and June 2020, 36 patients meeting inclusion criteria were identified. The research findings reveal a higher incidence of COVID-19 among males and a prevalent age group of 31-40 years. Notably, elderly individuals and those with underlying health conditions face a greater risk of severe outcomes, underscoring the importance of tailored interventions for vulnerable populations. The study highlights a diverse treatment approach, with a significant proportion of patients receiving supplements to bolster immune function. Antiviral medications like Favipiravir are also utilized to inhibit viral replication, although definitive treatment for COVID-19 remains elusive. Antibiotics play a crucial role in preventing bacterial respiratory infections, while supportive medications help alleviate symptoms commonly associated with the disease. Importantly, the findings emphasize the multifaceted nature of COVID-19 management and the need for targeted interventions to optimize patient outcomes. By elucidating the therapeutic landscape and clinical course of COVID-19 inpatients without comorbidities, this study contributes to the growing body of knowledge surrounding the disease. These insights can inform clinical decision-making, resource allocation, and public health strategies aimed at combating the ongoing pandemic.
KOMPONEN FITOKIMIA DAUN JAMBU BIJI (PSIDIUM GUAJAVA L.) DAN AKTIVITAS FARMAKOLOGISNYA Eva Dian Sari Marbun; Monica Suryani; Ilhawa Zahra; Rika Amelia
Jurnal Intelek Insan Cendikia Vol. 2 No. 1 (2025): JANUARI 2025
Publisher : PT. Intelek Cendikiawan Nusantara

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Daun jambu biji (Psidium guajava L) merupakan salah satu tanaman yang telah lama digunakan oleh masyarakat dalam pengobatan tradisional secara turun-temurun. Beberapa penelitian yang telah dilakukan membuktikan bahwa daun jambu biji mengandung beberapa senyawa fitokimia yaitu, tanin, flavonoid, saponin, alkaloid, minyak atsiri, dan triterpenoid. Tujuan dari pembuatan jurnal ini untuk mengetahui komponen fitokimia daun jambu biji dan aktivitas farmakologis. Dalam jurnal ini menggunakan metode literature review, metode ini cara untuk kita menggali informasi lebih spesifik dalam peninjauan yang berhubangan dengan khasiat daun jambu biji yang mengakses beberapa jurnal dan artikel Nasional maupun Internasional.
Co-Authors Eva Dian Sari Marbun Faisal Akhmal Muslikh Fendy Prasetyawan Monica Suryani Ratna Mildawati Rika Amelia Yuneka Saristiana